— Know what they know.
Not Investment Advice

2820.HK

Global X China Biotech ETF (HKD)
1W: +2.2% 1M: +4.0% 3M: +10.2% YTD: +5.0% 1Y: +0.6% 3Y: +30.6% 5Y: -43.0%
HK$76.32 ($9.73)
-1.66 (-2.13%)
 
Weekly Expected Move ±4.6%
HK$69 HK$73 HK$76 HK$80 HK$83
ETF HKSE · AUM HK$702.3M

Portfolio Health Summary

IS Overall Score
66.1
★★★★★
Altman Z-Score
14.51
Safe
Weight Coverage
96%
of portfolio analyzed
Holdings Matched
28
with fundamental data

InsiderStreet Scorecard

★★★★★ 66.1
Profitability
67.3
Balance Sheet
86.0
Earnings Quality
59.0
Growth
63.5
Value
51.4
Momentum
78.7
Safety
96.7

Top Holdings: Score Breakdown

Risk & Quality Signals

Altman Z-Score
14.51
Safe Zone (>2.99)
Piotroski F-Score
5.9 / 9
Moderate
Beneish M-Score
-2.05
Unlikely Manipulator
Credit Score
—
Earnings Quality
59.0 / 100

Portfolio Valuation

P/E
25.27x
P/B
4.95x
P/S
6.67x
EV/EBITDA
15.85x
EV/Revenue
5.81x
P/FCF
28.66x
P/OCF
19.63x
PEG
0.89x
Earnings Yield
3.96%
FCF Yield
3.49%
OCF Yield
5.09%
Median P/E
21.08x

Growth & Shareholder Returns

Year-over-Year Growth

Revenue +34.1%
Net Income +69.9%
EPS +67.6%
FCF +74.0%
EBITDA +74.0%
Op. Income —

Compound Growth Rates

Rev CAGR 3Y +42.9%
Rev CAGR 5Y +27.4%
EPS CAGR 3Y +28.5%
EPS CAGR 5Y +25.1%
FCF CAGR 3Y +29.3%
FCF CAGR 5Y +157.6%
EBITDA CAGR 3Y +43.7%
EBITDA CAGR 5Y +25.0%
Payout Ratio
16.71%
Buyback Yield
0.43%
Dividend Yield
0.73%
Total Shareholder Return
1.44%

Earnings Stability

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1747 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$76.34
Median 1Y
$76.19
5th Pctile
$44.13
95th Pctile
$132.15
Ann. Volatility
35.4%
25th–75th percentile 5th–95th percentile Median path Historical
All Ratios & Metrics
Valuation (12)
MetricValue
Portfolio P/E 25.27
Portfolio P/B 4.95
Portfolio P/S 6.67
EV/EBITDA 15.85
EV/Revenue 5.81
P/FCF 28.66
P/OCF 19.63
PEG 0.89
Earnings Yield 3.96%
FCF Yield 3.49%
OCF Yield 5.09%
Median P/E 21.08
Profitability & Returns (9)
MetricValue
Gross Margin 65.46%
Operating Margin 29.40%
Net Margin 25.76%
FCF Margin 22.68%
ROE 21.31%
ROA 14.98%
ROIC 30.73%
ROCE —
Asset Turnover —
Leverage & Solvency (6)
MetricValue
Debt/Equity 0.15
Debt/Assets 0.10
Net Debt/EBITDA -1.54
Interest Coverage 65.43
Current Ratio 3.00
Quick Ratio 2.69
Efficiency (4)
MetricValue
Asset Turnover —
Inventory Turnover —
Receivables Turnover —
Payables Turnover —
Growth — YoY (6)
MetricValue
Revenue Growth 34.12%
Net Income Growth 69.86%
EPS Growth 67.61%
FCF Growth 74.00%
EBITDA Growth 73.96%
Op. Income Growth —
Growth — CAGR (16)
MetricValue
Revenue CAGR 3Y 42.88%
Revenue CAGR 5Y 27.36%
Revenue CAGR 10Y —
EPS CAGR 3Y 28.50%
EPS CAGR 5Y 25.07%
EPS CAGR 10Y —
FCF CAGR 3Y 29.33%
FCF CAGR 5Y 157.56%
FCF CAGR 10Y —
EBITDA CAGR 3Y 43.74%
EBITDA CAGR 5Y 25.04%
EBITDA CAGR 10Y —
Net Income CAGR 3Y 29.04%
Net Income CAGR 5Y 27.56%
Op. Income CAGR 3Y —
Op. Income CAGR 5Y —
Quality Scores (13)
MetricValue
IS Overall 66.1
IS Profitability 67.3
IS Balance Sheet 86.0
IS Earnings Quality 59.0
IS Growth 63.5
IS Value 51.4
IS Momentum 78.7
IS Safety 96.7
IS Quality 74.9
Altman Z-Score 14.51
Piotroski F-Score 5.92
Beneish M-Score -2.05
Credit Score —
Dividends & Payout (4)
MetricValue
Dividend Yield 0.73%
Payout Ratio 16.71%
Buyback Yield 0.43%
Total Shareholder Return 1.44%
Growth Stability (4)
MetricValue
Revenue Stability 0.752
Earnings Stability 0.571
Earnings Persistence 0.547
Margin Stability 0.888
Medians (3)
MetricValue
Median P/E 21.08
Median P/B 4.17
Median Dividend Yield —
Coverage Meta (3)
MetricValue
Weight Coverage % 96.00%
Holdings Matched 28
Total Holdings —

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms